Evidence map›Paper›PMID 28495587›Full record

ArticleFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2017

Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants.

Isabelle R Miousse, Lynea A Murphy, Haixia Lin, Melissa R Schisler, Jinchun Sun, Marie-Cecile G Chalbot, Radhakrishna Sura, Kamin Johnson, Matthew J LeBaron, Ilias G Kavouras and 4 more

Abstract read
In one paragraph

Article in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Loci specific epigenetic drug sensitivity.Nucleic acids research · 2020
    Article
  6. Article
  7. Review
  8. Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2018
    Article
  9. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2017
    Review
  10. Safety assessment of the dietary supplement OxyELITE™ Pro (New Formula) in inbred and outbred mouse strains.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Isabelle R MiousseDepartment of Environmental and Occupational Health, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. Electronic address: IRacinemiousse@uams.edu.
Lynea A MurphyToxicology and Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: Murphy3@dow.com.
Haixia LinDepartment of Environmental and Occupational Health, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. Electronic address: HLin@uams.edu.
Melissa R SchislerToxicology and Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: MRSchisler@dow.com.
Jinchun SunDivision of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: Jinchun.Sun@fda.hhs.gov.
Marie-Cecile G ChalbotDepartment of Environmental Health Sciences, Ryals School of Public Health, University of Alabama at Birmingham, 1665 University Blvd, Birmingham, AL 35246, USA. Electronic address: chalbot@uab.edu.
Radhakrishna SuraToxicology and Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: radhakrishna.sura@abbvie.com.
Kamin JohnsonToxicology and Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: kjjohnson2@dow.com.
Matthew J LeBaronToxicology and Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: mjlebaron@dow.com.
Ilias G KavourasDepartment of Environmental Health Sciences, Ryals School of Public Health, University of Alabama at Birmingham, 1665 University Blvd, Birmingham, AL 35246, USA. Electronic address: kavouras@uab.edu.
Laura K SchnackenbergDivision of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: Laura.Schnackenberg@fda.hhs.gov.
Richard D BegerDivision of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: Richard.Beger@fda.hhs.gov.
Reza J RasoulpourToxicology and Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: RRasoulpour@dow.com.
Igor KoturbashDepartment of Environmental and Occupational Health, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. Electronic address: IKoturbash@uams.edu.

Funding

The Role o f Tetrahydrobiopterin (BH4) Bioavailability in Radiation-induced Skin InjuryP20GM109005 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI PARKER, PEARMAN · 2015 to 2024
$21.1M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Arkansas Center for Clinical Translational ResearchKL2TR000063 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$459k
NCATS NIH HHS KL2 TR000063NCATS NIH HHS UL1 TR000039NIGMS NIH HHS P20 GM109005
6 · The paper itself

Abstract

Identification of sensitive and novel biomarkers or endpoints associated with toxicity and carcinogenesis is of a high priority. There is increasing interest in the incorporation of epigenetic and metabolic biomarkers to complement apical data; however, a number of questions, including the tissue specificity, dose-response patterns, early detection of those endpoints, and the added value need to be addressed. In this study, we investigated the dose-response relationship between apical, epigenetic, and metabolomics endpoints following short-term exposure to experimental hepatotoxicants, clofibrate (CF) and phenobarbital (PB). Male F344 rats were exposed to PB (0, 5, 25, and 100 mg/kg/day) or CF (0, 10, 50, and 250 mg/kg/day) for seven days. Exposure to PB or CF resulted in dose-dependent increases in relative liver weights, hepatocellular hypertrophy and proliferation, and increases in Cyp2b1 and Cyp4a1 transcripts. These changes were associated with altered histone modifications within the regulatory units of cytochrome genes, LINE-1 DNA hypomethylation, and altered microRNA profiles. Metabolomics data indicated alterations in the metabolism of bile acids. This study provides the first comprehensive analysis of the apical, epigenetic and metabolic alterations, and suggests that the latter two occur within or near the dose response curve of apical endpoint alterations following exposure to experimental hepatotoxicants.

Indexed as

AnimalsClofibrateCytochrome P-450 Enzyme SystemDNA MethylationDose-Response Relationship, DrugEpigenomicsGene ExpressionLiverMalePhenobarbitalRatsRats, Inbred F344ClofibrateCytochrome P-450 Enzyme SystemPhenobarbitalBenchmark dose modelingDNA methylationDose-responseHepatotoxicantsLINE-1MetabolomicsmiRNA

Identifiers

PMID28495587
PMCPMC5656539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.